Nitra Secures $187 Million in Multi-Stage Financing
Nitra has raised $187 million across its Series A and Series B rounds, venture debt and a warehouse facility. The latest raise brings total capital to $205 million. It also increases total equity raised to $90 million.
The company’s financing follows a breakout year. It grew revenues by more than 740% in 2025. It also surpassed $1 billion in annualised processing volume. The new equity component includes $72 million. A $50 million Series B round led the raise.
It also includes a previously undisclosed $22 million Series A completed in August 2025. The investor group features Actions Capital, AppWorks, Comma Capital, Dunamu & Partners, Era Funds, New Enterprise Associates (NEA), Pantera Capital and Sazze Partners.
Additional investors include AAF, Gaingels, Hyphen Capital, K8, Mana Ventures, Necessary Ventures, PIDC/Uni-President, Purestone Silks, SignalRank, Simu Liu’s Markham Valley Ventures, Soma Capital and others.
Nitra also secured $20 million in venture debt from Avenue Capital Group. The firm expanded its warehouse facility to $95 million in partnership with Treville Capital Group and Encina Lender Finance.
A New Operating System for Healthcare Providers
Nitra operates an AI-native platform designed to help healthcare practices manage core administrative and financial workflows. The company was founded in 2024 by CEO Tim Hwang and President Jonathan Chen.
They built the system to address inefficiencies in the United States healthcare industry. Almost $5.9 trillion is spent annually. Around 25% of that spending is administrative. Nitra embeds AI into the operational backbone of clinics. Its platform consolidates payments, procurement, inventory, scheduling and insurance verification.
Healthcare practices often rely on disconnected systems. Nitra unifies these through a single operating environment. It gives doctors and their teams more control over daily workflows. Nitra’s financial automation tools include a Visa-powered expense card, bill pay services, patient payments and AI-driven accounting.
The platform also supports a commerce and inventory marketplace. Practices can access biopharmaceuticals and equipment through partners such as McKesson and Medline. AI agents negotiate prices and manage suppliers. They also maintain inventory and execute purchases.
Patient Management and AI Growth
Nitra recently launched a patient management module. It includes voice-based AI agents. These agents handle scheduling and insurance eligibility checks. They integrate communication and benefits verification with the broader operational stack. This reduces administrative burden on physicians and staff.
The company’s platform is already used by thousands of doctors. It supports more than 700 clinics. In December 2025, Nitra processed nearly $9 million in biopharma and medical purchases in a single day. Annualised revenue grew from $4 million to more than $33 million during 2025.
A trusted external report from McKinsey & Company highlights the rising importance of AI in clinical operations. It notes that automation can reduce administrative effort significantly. It also notes strong demand for tools that improve operational visibility.
Scaling Into 2026 and Beyond
Nitra plans rapid growth in 2026, expanding AI modules and operational automation across 3,000+ clinics while scaling its workforce and revenue. Source: Created by Ventureburn.
The company expects rapid expansion. It aims to serve more than 3,000 clinics in 2026. It also targets more than $150 million in annualised revenue. It expects to exceed $4 billion in annualised processing volume. Headcount will grow from around 50 people to more than 200.
Nitra will introduce new AI modules. These include revenue cycle management, patient marketing and payroll systems. The company plans to increase automation depth across healthcare operations. It believes AI-native infrastructure will become essential for medical practices.
Dr Richard Park has joined Nitra’s board. Park is the founder and former CEO of CityMD. He oversaw its merger with Summit Health. The combined entity was acquired by VillageMD for $8.9 billion in 2023. Park now leads Ascend Partners as co-founder and Managing Partner. His experience strengthens Nitra’s leadership as the company scales.
More News: Armadin Secures $189.9M to Build Autonomous AI Defence Against Hyperattacks
Investor Perspectives and Market Opportunity
Adarsh Bhatt of Comma Capital said Nitra is creating a new category for healthcare practices. He said the fintech entry point provided access to larger operational opportunities. He noted strong demand from clinicians for modern infrastructure.
Dan Holman of Avenue Capital Group said his firm’s $20 million venture debt commitment reflects confidence in Nitra’s momentum. He said founders Hwang and Chen have a strong track record. He believes Nitra will become essential infrastructure for practices.
Nitra previously raised its seed round in 2022. Participants included Andreessen Horowitz, NEA, Pantera Capital, KB Financial Group, AME Cloud Ventures, Gold House Ventures, Dreamers VC and others.
Hwang said Nitra’s mission is to help doctors save time and money. He said practices run critical workflows across disconnected systems. He believes Nitra’s operating system brings these layers together. This supports more efficient operations.
To stay updated on crypto venture capital funding and market trends, visit our venture capital news section for more insights.
